大剂量甲基强的松龙治疗多发性硬化的疗效观察被引量：9

下载PDF

导出

摘要目的通过临床疗效对比,观察大剂量甲基强的松龙治疗多发性硬化的近期疗效。方法选取在我科就诊的多发性硬化患者50例,随机分为治疗组和对照组各25例。治疗组给予甲基强的松龙1 g静滴,5 d后改为口服强的松50 mg/d,逐渐减量。对照组给予地塞米松15 mg静滴10 d,逐渐减量。结果治疗10 d后,治疗组症状缓解22例,有效率为88.0%;对照组症状缓解7例,有效率为28.0%,两组差异有统计学意义(P<0.01)。结论短期大剂量甲基强的松龙治疗对多发性硬化患者症状缓解明显,近期疗效显著,值得临床推广。

作者田松琴张义罗亨勤

机构地区解放军

出处《西南国防医药》 CAS 2015年第5期528-529,共2页 Medical Journal of National Defending Forces in Southwest China

关键词甲基强的松龙多发性硬化疗效

分类号 R744.5 [医药卫生—神经病学与精神病学]

引文网络
相关文献

参考文献7

1Kurtzke JF.Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) [J]. Neurology, 1983,33(11):1444.
2Noseworthy JH, Lucehinetti C, Rodfiguez M, et al.Multiple sclerosis[J].N Engl J Med,2000,343(13):938.
3周文斌,朱世津,汤新年,杨欢,肖波,谢光洁.甲基强的松龙对多发性硬化免疫功能的影响[J].中国神经免疫学和神经病学杂志,2000,7(3):152-156. 被引量：21
4Hall ED, High-dose glucocorticoid treatment improves neurological recovery in head-injured mice [J].J Neurosurgery, 1995,62:882.
5Schmidt J, Gold R, Schonrock L, et al. T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylpredniselone pulse therapy[J]. Brain,2000,123:1431.
6Griftths TD,Newman PK.Steroids in multiple sclerosis [J].J Clin Pharm Ther,1994,19(4):219.
7Durel li L, Cocito D, Riccoi A, et al. High-dose intravenous methylprednisolone in the treatment of multiple sclerosis" clinical-immunologic eorrelation[J].Neurology,2003,36:238.

二级参考文献9

1[1] Ffrench-Constant C. Pathogenesis of multiple sclerosis[J]. Lancet, 1994,343:271-275.
2[2] Beck J,Rondot P, Catinot L,et al. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?[J] Acta Neurol Scand, 1988,78:318-323.
3[3] Griftths TD, Newman PK. Steroids in multiple sclerosis[J]. J Clin Pharm Ther, 1994,19:219-222.
4[4] Poser CM , Paly UM, Scheinbre L. New diagnostic criteria for multiple sclerosis guidelines for research protocols[J]. Ann Neurol, 1983,13:227-231.
5[5] Yagi Y, Takahashi M, Nakamura Y. Cytokine-secreting cells in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone[J]. Rinsho Shinkeigaku, 1997,37(7):575-579.
6[6] Gelati M, Corsini E, Dufour A, et al. Reduced adhesion of PBMNCs to endothelium in methylprednisolone-treated MS patients: preliminary results[J]. Acta Neurol Scand, 1997,96(5):283-392.
7[7] De Waat-Malefyt R, Haanen J, Spits H,et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class Ⅱ major histocompatibility complexes expression[J]. J Exp Med, 1991,174:915-924.
8[9] Gayo A, Mozo L, Sulez A, et al. Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse[J]. J Neuroimmunol, 1998,85:122-30.
9周文斌.多发性硬化患者周围血单核细胞的IL-10分泌细胞变化及意义[J].中华神经科杂志,1998,31(6):339-341. 被引量：11